Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Targeted protein degradation is changing how drug discovery teams think about disease biology. For many years, small molecule programs were built around inhibition. | Explore how targeted protein degradation is reshaping drug discovery, enabling new approaches for difficult targets and advancing novel therapeutic modalities.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

By Moitreyee Chatterjee-Kishore, Ph.D., MBA, Head of Oncology Development, Astellas Pharma Inc. | How targeted protein degraders…

Modern drug development demands faster, more scalable gene expression insights. Download this white paper to explore how…

How can timely, precise lab data improve decision-making across the medicine lifecycle? Download this whitepaper to explore how…

Drug commercialization depends on reaching the right physicians at the right moment. | Drug commercialization depends on reaching…

Combination strategies are rapidly redefining treatment for HER2-positive solid tumors. | HER2 combination strategies are…

Strengthening core CDO values for cell line development | Strengthening core CDO values for cell line development